Early research (Phase 1)Study completedNCT00420043What this trial is testingEffect of Food on Bioavailability of Modified Release Formulations of ImatinibWho this might be right forHealthy Novartis 32
Testing effectiveness (Phase 2)Study completedNCT02523976What this trial is testingDasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaWho this might be right forAcute,Leukemia, Lymphoid Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT05216068What this trial is testingInvestigation and Diagnosis of the Chromosome Variation in Donated/abandoned BlastocystWho this might be right forChromosome TranslocationGenetic Disorders in PregnancyRecurrent Miscarriage Chang Gung Memorial Hospital 57
Testing effectiveness (Phase 2)Study completedNCT00130195What this trial is testingStudy of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Japan Adult Leukemia Study Group 100
Early research (Phase 1)Study completedNCT01471067What this trial is testingCord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesWho this might be right forBlood And Marrow TransplantationLeukemiaLymphoma+2 more M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT00428909What this trial is testingEffect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)Who this might be right forChronic Myeloid Leukemia (CML) Novartis Pharmaceuticals 12
Not applicableStudy completedNCT00001120What this trial is testingPatients With AIDS SyndromeWho this might be right forSarcoma, KaposiLymphoma, Non-HodgkinHIV Infections+1 more National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Testing effectiveness (Phase 2)Study completedNCT00171223What this trial is testingAn Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-AlphaWho this might be right forLeukemia, Myelogenous, Chronic, BCR-ABL Positive Novartis Pharmaceuticals 532
Testing effectiveness (Phase 2)Study completedNCT00287105What this trial is testingSafety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in ChildrenWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia Chromosome Rennes University Hospital 49
Not applicableStudy completedNCT03509896What this trial is testingStudy of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)Who this might be right forChronic Myeloid LeukemiaPhiladelphia ChromosomeChronic Myeloid Leukemia in Chronic Phase Bristol-Myers Squibb 463
Testing effectiveness (Phase 2)Ended earlyNCT00140855What this trial is testingAnti-CTLA-4 Antibody in Patients With Advanced Synovial SarcomaWho this might be right forSynovial Sarcoma Ludwig Institute for Cancer Research 6
Testing effectiveness (Phase 2)Study completedNCT01745640What this trial is testingPomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)Who this might be right forMultiple Myeloma University Hospital, Lille 63
Testing effectiveness (Phase 2)UnknownNCT03249870What this trial is testingStudy of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALLWho this might be right forAcute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) Versailles Hospital 130
Testing effectiveness (Phase 2)WithdrawnNCT04845035What this trial is testingPediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia University of Michigan Rogel Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04971226What this trial is testingOral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPWho this might be right forChronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Novartis Pharmaceuticals 406
Testing effectiveness (Phase 2)Looking for participantsNCT05442515What this trial is testingCD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell MalignanciesWho this might be right forB-NHLB-Non Hodgkin LymphomaAcute Lymphocytic Leukemia+8 more National Cancer Institute (NCI) 126
Testing effectiveness (Phase 2)Looking for participantsNCT06220487What this trial is testingA Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALLWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia ChromosomePhiladelphia-Positive ALL+2 more Nanfang Hospital, Southern Medical University 67
Testing effectiveness (Phase 2)Study completedNCT00171158What this trial is testingAn Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast CrisisWho this might be right forPhiladelphia Chromosome Positive CML Novartis Pharmaceuticals 260
Large-scale testing (Phase 3)Study completedNCT01254188What this trial is testingSafety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia PatientsWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 421
Very early researchUnknownNCT01826708What this trial is testingBreakpoint Analysis of de Novo Apparently Balanced Chromosomal TranslocationsWho this might be right forBalanced Chromosomal Translocation University Hospital, Montpellier 10